Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study
about
Advances in the epidemiology of heart failure and left ventricular remodelingClinical Phenotypes in Heart Failure With Preserved Ejection FractionRelationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failureBiomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.Association between depressive symptoms and fibrosis markers: the Cardiovascular Health Study.Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health studyCirculating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failureFibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruziPost-operative atrial fibrillation: a maze of mechanisms.The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health StudyCardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction.Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study.Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension.Matrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heartAssociations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.Interactions of Short-Term and Chronic Treadmill Training With Aging of the Left Ventricle of the HeartSecondhand Smoke Exposure Enhances Cardiac Fibrosis Effects on the Aging Rat Hearts.Integrating the myocardial matrix into heart failure recognition and management.Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.Heart failure as a risk factor for osteoporosis and fractures.Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.Biomarkers of heart failure with normal ejection fraction: a systematic review.Circulating biomarkers in patients with heart failure and preserved ejection fraction.MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure.Increased type I collagen synthesis in victims of sudden cardiac death due to idiopathic myocardial fibrosis.Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy.Effects of low-frequency noise on cardiac collagen and cardiomyocyte ultrastructure: an immunohistochemical and electron microscopy study.Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study.Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis).Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans
P2860
Q26827147-ED7FCF96-83EE-4A0C-B3C1-7C798BBA813EQ28073079-57B47B17-082C-481B-8627-FB40B8B17869Q28483052-C04D767E-93A9-4753-BF39-1B331D688BF1Q33559608-480729FC-CB1D-4155-BA1A-7E521CC67560Q33637776-78A9323D-A36D-4F5F-804D-5267B47C2673Q33676034-D7E6FB54-E0A0-43C1-B458-3AD5994C169DQ33765348-974DC649-94FA-4B61-BA00-A0809C276E8FQ33810217-6C07C052-5A26-4A62-A9AA-DE15340954B3Q34076151-AF0C5DC6-3EE9-4B2A-8F9D-6B6908C61238Q34587023-B00884C2-F8A2-479B-B72B-5A6F6FFC4D43Q35684027-ECAE0DCD-8248-4349-9148-7C138E133712Q35686798-623EA942-5F96-44EC-98C7-89D561BBA314Q35777180-B7EA7444-1E22-4F6E-9967-C1B761AD9666Q36053833-DE663A8B-AA00-4661-A766-EE4924BDE195Q36288050-4ECFC4E9-09F1-458D-B80A-357AEE058252Q36359610-96C21D69-8000-440E-8B6F-3865755CF25CQ36931178-811EF8AD-FBA2-4797-86E6-CD735B85A824Q37032185-1C0E579D-2271-47E0-BD75-C23EC24A44DFQ37041149-387E6BCB-B255-4850-A660-4341CFD069F8Q37082373-684A2CE5-BD7F-4817-BBB5-1EB2E42286EAQ37096456-2EB2CF01-58AF-45BC-8620-DADE41329E20Q37314530-72C48A7E-2BA9-4600-ABF6-67CB8C69C743Q37406111-AD599D0E-7770-48E4-B7B1-E25D01B707DFQ37419451-4229E3EF-1D60-4A81-8C6B-42BB6D34F2FBQ37924999-E7DA9149-C8A8-47A6-88EB-E063C9EB42D2Q38036949-932BBB2E-8EB5-43C1-8EB8-EDE773F19D6FQ38110226-F5B98506-D8FE-4D1A-9D36-42A27F10A045Q38120919-F5747BB3-4522-48EA-91A7-54B447621BC8Q38152289-A4117151-5E96-42D4-987D-EF60B78317CAQ38705786-BB744BDF-E724-4EFB-8FC6-EE3FF29676B4Q39195389-E8073656-3E6D-44EC-954D-E58641504AF3Q40724074-2E1829DB-18BA-412B-977D-582E5B18D9F1Q41857179-76E1A9B9-22B6-47F8-9E7C-F23D0D1E9633Q42679350-7B634053-409F-4931-B7E5-01AA4C729765Q47392248-DE18A2C4-CAF0-49DA-B06B-80981A09BCB6Q47677252-2DBB7BB1-4DB2-4B9B-833D-4B7DFCB4CBA6Q49106557-81E832E4-9176-4F2B-AFC2-DD9A7B5DC6F1Q50639398-749C1831-842B-43CF-9EB4-E1D63CB07DE9Q55434646-54FD1CC0-BECB-49FF-B013-B179390AE2C0Q58752679-5C677CD7-62AD-45FE-9E0B-90AFD3F55E3E
P2860
Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Association between elevated f ...... he cardiovascular health study
@ast
Association between elevated f ...... he cardiovascular health study
@en
Association between elevated f ...... he cardiovascular health study
@nl
type
label
Association between elevated f ...... he cardiovascular health study
@ast
Association between elevated f ...... he cardiovascular health study
@en
Association between elevated f ...... he cardiovascular health study
@nl
prefLabel
Association between elevated f ...... he cardiovascular health study
@ast
Association between elevated f ...... he cardiovascular health study
@en
Association between elevated f ...... he cardiovascular health study
@nl
P2093
P2860
P1476
Association between elevated f ...... he cardiovascular health study
@en
P2093
Dalane W Kitzman
Eddy Barasch
Gerard Aurigemma
John S Gottdiener
Russell P Tracy
Willem J Kop
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.108.828343
P577
2009-05-14T00:00:00Z